ACM Research, Inc. (ACMR) AI Stock Analysis
ACMR AI stock analysis summary
AI ResearchACM Research, Inc. (NASDAQ: ACMR) develops and sells advanced single-wafer wet cleaning and wet processing equipment for semiconductor manufacturing. Over the trailing twelve months, revenue reached $1.04B with an operating margin of 17.0%. The company holds $1.46B in cash and short-term investments against $349.3M in total debt as of June 30, 2026.
- Market cap
- $3.70B
- Revenue (TTM)
- $1.04B
- P/E
- 25.0x fwd 30.2x
- 1Y return
- 33.8% S&P 500 16.8%
- Avg. target
- $115.33 117.2% vs last close
Bull case
- Revenue expanded at a 5-year compound annual growth rate of 41.9% through FY2025, driven by demand for advanced chip cleaning tools.
- The balance sheet maintains solid liquidity with $1.11B in net cash and a current ratio of 3.66 as of June 30, 2026.
- In the quarter ended June 30, 2026, quarterly earnings grew 180.6% year-over-year on 36.0% revenue growth.
Bear case
- Free cash flow remained negative at -$66.6M in FY2025, marking four years of cash outflows out of the last five fiscal years.
- Operating margin declined from 19.3% in FY2024 to 12.1% in FY2025 as research and development expense rose to $145.0M.
- The stock carries elevated volatility with a beta of 2.09 and traded 22.4% below its 200-day moving average as of October 16, 2026.
What ACM Research does
ACM Research, Inc., along with its subsidiaries, develops, manufactures, and sells advanced single-wafer wet cleaning equipment designed to enhance the manufacturing process and yield of integrated chips globally. Its proprietary solutions include space alternated phase shift technology, timely energized bubble oscillation for advanced process nodes, and Tahoe technology, which reduces chemical usage such as sulfuric acid and hydrogen peroxide. The company also offers electro-chemical plating technology to support advanced metal plating. Products are marketed under the Ultra C brand name through a direct sales force and third-party representatives.
Growth and profitability
Revenue increased from $259.8M in FY2021 to $901.3M in FY2025, delivering a 5-year revenue compound annual growth rate of 41.9%. Over that span, gross margin moved from 44.2% in FY2021 to a high of 50.1% in FY2024 before settling at 44.4% in FY2025. Operating margin was 12.1% in FY2025, down from 19.3% in FY2024, while net income totaled $94.1M. In the latest quarter ended June 30, 2026, quarterly revenue expanded 36.0% year-over-year and quarterly earnings grew 180.6% year-over-year.
Balance sheet and cash flow
As of June 30, 2026, ACM Research held $1.46B in cash and short-term investments alongside $349.3M in total debt, resulting in a net cash position of $1.11B. Total assets stood at $3.40B, supported by $1.86B in shareholders' equity. The company reported a current ratio of 3.66 and a debt-to-equity ratio of 0.19. During FY2025, free cash flow was -$66.6M, while capital expenditures were $56.3M, share buybacks totaled $7.0M, and dividends paid were $7.6M.
Valuation and performance
At a last close of $53.10, ACM Research traded at a trailing price-to-earnings ratio of 25.0x, below the 28.1x median of its US-listed Technology peers. Its forward price-to-earnings ratio was 30.2x, compared to the peer median of 18.8x, and its enterprise value-to-EBITDA was 17.1x versus the peer median of 16.6x. Over the past year, the stock returned 33.8%, outpacing the S&P 500 return of 16.8%, but its 5-year return of 51.3% trailed the S&P 500 return of 83.0%.
What analysts expect
Wall Street coverage includes 6 Strong Buy, 3 Buy, and 1 Hold ratings, with zero Sell ratings. The mean price target of $115.33 represents an upside of 117.2% from the last close of $53.10. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $1.17B and an earnings per share of $2.14, representing 32.9% earnings growth. Over the last four quarters, the company exceeded earnings estimates twice, with the next earnings announcement scheduled for November 4, 2026.
Key risks and what to watch
- Free cash flow was -$66.6M in FY2025, which could pressure liquidity if operating cash flow does not sustain positive levels.
- The forward price-to-earnings multiple of 30.2x sits above the peer median of 18.8x, leaving the valuation vulnerable to earnings misses.
- The company's high beta of 2.09 reflects substantial price swings, as seen in its 52-week range between $28.46 and $127.19.
- Short interest stands at 7.5% of the float, signaling cautious sentiment among some market participants.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this ACMR AI stock analysis
This page is an AI-written research summary of ACM Research, Inc. (ACMR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: ACMR income statement, ACMR balance sheet, ACMR key metrics, ACMR analyst forecast, ACMR chart. See the ACMR stock overview for the latest quote and news.
ACMR AI stock analysis FAQ
What is ACM Research's net cash position?
As of June 30, 2026, ACM Research had $1.46B in cash and short-term investments and $349.3M in total debt, leaving net cash of $1.11B.
What are analysts forecasting for ACMR's earnings?
For the fiscal year ending December 31, 2026, analysts estimate earnings per share of $2.14 on revenue of $1.17B. For the following fiscal year, 5 analysts project earnings per share of $2.94 on revenue of $1.51B.
How has ACMR stock performed relative to the broader market?
ACMR gained 33.8% over the past year compared to a 16.8% return for the S&P 500. Over five years, the stock returned 51.3%, lagging the S&P 500 return of 83.0%.
When does ACM Research report its next quarterly earnings?
The company's next earnings date is scheduled for November 4, 2026.